NetworkNewsBreaks

MondayMay 14, 2018 3:00 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Awaiting Patent for Promising DehydraTECH Transdermal CBD Application

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) continues to add numerous U.S. and Australian patents to its existing portfolio. Among these is the company’s recent filing for a new transdermal application of cannabidiol (CBD) that followed successful laboratory evaluation of DehydraTECH delivery results. An article discussing the company reads: "LXRP is a British Columbia-based, cannabis-focused food bioscience company, and it is a technology disrupter for edible cannabinoids. Its DehydraTECH technology aids in the body’s absorption of cannabinoids. ... The company’s most recent patent filing follows successful laboratory evaluation of DehydraTECH in the transdermal delivery of cannabidiol (CBD). Results showed an…

Continue Reading

MondayMay 14, 2018 12:43 pm

NetworkNewsBreaks – ARCA Biopharma, Inc. (NASDAQ: ABIO) Posts Q1 Financial Results, Pipeline Progress; Presenting Clinical Trial Results at Heart Failure 2018 World Congress

ARCA biopharma (NASDAQ: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, recently reported financial results for the quarter ended March 31, 2018, as well as an update regarding its lead product candidate, Gencaro™. Among other highlights, the company reported ending the quarter with cash, cash equivalents and marketable securities of $12.1 million, compared to $11.8 million as of December 31, 2017. The company has scheduled an end-of-phase 2 meeting with the U.S.  Food and Drug Administration (“FDA”) for the last week of June to review data from the GENETIC-AF clinical trial and…

Continue Reading

MondayMay 14, 2018 11:16 am

NetworkNewsBreaks – Xanthic Biopharma Inc. (CSE: xTHC) Inks LOI with Nutritional High International Inc. (CSE: EAT) (OTCQB: SPLIF) for Production, Distribution of CBD-infused Powders

Xanthic Biopharma (CSE: xTHC) recently announced that it has entered into a binding Letter of Intent ("LOI") with Nutritional High International (CSE: EAT) (OTCQB: SPLIF) for the production and distribution of Xanthic branded water-soluble cannabis-infused powders in California. Per the agreement, Nutritional High's Californian subsidiaries, Pasa Verde and Calyx, will distribute Xanthic's cannabis-infused powder products. "The Xanthic team is thrilled to advance our strategic relationship with Nutritional High in California. By utilizing the Nutritional High's vertically integrated network, Xanthic will be able to exploit the significant market opportunity represented by the state of California. This new agreement provides value to…

Continue Reading

MondayMay 14, 2018 11:02 am

NetworkNewsBreaks – American Resources Corporation (AREC) Obtains Additional Mining Equipment Aimed at Increasing Production

Diversified energy services company American Resources Corporation (OTC: AREC), through wholly owned subsidiary Quest Energy Inc., last week announced that it has secured additional key pieces of underground mining equipment that will allow the company to expand its existing coal production at several select mining operations. Per the update, this equipment includes continuous miners, shuttle cars and other support equipment. “We are very pleased to have obtained this equipment to allow us to increase production at our Deane Mining and McCoy Elkhorn subsidiaries,” Mark Jensen, CEO of American Resources Corporation, stated in the news release. “Our team has worked hard…

Continue Reading

MondayMay 14, 2018 10:21 am

NetworkNewsBreaks – Millennial Lithium Corp. (TSXV: ML) (FSE: A3N2) (OTCQX: MLNLF) Secures Seasoned Industry Expert; Provides Update

Millennial Lithium Corp. (TSXV: ML) (FSE: A3N2) (OTCQX: MLNLF) this morning reported that it has engaged Peter Ehren, an experienced industry expert in evaporative processes for lithium production. Ehren's responsibilities will include completing the evaporation ponds system in a way that is compatible with the Pastos Grandes project brine chemistry, overseeing the computer modelling of the ponds and designing and monitoring the further development of the on-site large-scale evaporation trials project. The company also provided an update regarding the progress on its technical programs. Among other highlights, the company has initiated exploration and development activities on the REMSA ground including…

Continue Reading

MondayMay 14, 2018 10:04 am

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Arrival of Dried Cannabis Materials for Research Program

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the arrival of its second shipment of dried cannabis materials at the Pharmacy Australia Centre of Excellence (“PACE”) at the University of Queensland. Per the update, the shipment came from PreveCeutical’s partner, a Canadian licensed producer. Moving forward, the cannabis materials will be used for the company’s soluble gel (“Sol-gel”) drug delivery research program. The program, which is being led by PreveCeutical Chief Research Officer Dr. Harendra Parekh and conducted by the University of Queensland, involves testing an array of cannabis strains for the development…

Continue Reading

MondayMay 14, 2018 9:35 am

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) CEO to Give Keynote Presentation at Benchmark Mineral Intelligence Event

Cobalt exploration and development company First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) this morning announced that its president and CEO, Trent Mell, will be giving a keynote presentation on the cobalt market supply and demand fundamentals at a Benchmark Mineral Intelligence event in Vancouver on Wednesday, May 16, 2018, at 11:30 am. Per the update, the presentation will take place within the Benchmark Pavilion at the International Mining Investment Conference Vancouver at the Vancouver Convention Centre East. The Pavilion will focus on the lithium-ion battery and electric vehicle markets, while Mell’s presentation is expected to include a review of cobalt…

Continue Reading

MondayMay 14, 2018 9:22 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Launches Bitcoin Talk Show

Premier financial information company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of "Bitcoin Talk Show", a cryptocurrency and blockchain talk show airing on Phoenix North America Chinese Channel. The company has entered into a one-year contract with Phoenix North America to air the Bitcoin Talk Show once a month. The pioneering television program is set to begin airing the first week of June 2018. Local Chinese investors and business owners are invited to discuss cryptocurrency and blockchain technology with the company's Newcoins168.com analysts during a live taping at the Phoenix North America headquarters. In addition to the audience…

Continue Reading

FridayMay 11, 2018 3:03 pm

NetworkNewsBreaks – Consorteum Holdings, Inc. (CSRH) to Launch Cricket App and Expansions in Fintech

Consorteum Holdings, Inc. (OTC: CSRH) will be launching its Cricket DV-PA app this summer, the result of a strategic convergence of innovative technology behind Consorteum subsidiary 359 Mobile, Inc.’s Universal Mobile Interface (UMI) and DevLex Ltd.’s mobile analytics solutions. A recent article indicates that the move is not only a game-changer for cricket enthusiasts, but the first of many financial technology endeavors for CSRH, stating, “The upcoming launch of the cricket app is just the latest of Consorteum’s joint business agreements to capitalize on its fintech focus. One primary target of the UMI platform has been the mobile gaming industry,…

Continue Reading

FridayMay 11, 2018 2:25 pm

NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Leverages Innovative Technologies for Improved Cannabinoid Product Delivery

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) holds significant patents and a cannabinoid product portfolio designed with disruptive technologies that strive to maximize bioavailability, stability and drug release rates. A recent article highlights PVOTF’s innovative delivery technologies, indicating, “Some patents maintain the company’s impetus in making cannabis available through powdered formulations that can be combined with products in the food and beverage market. Through subsidiary Thrudermic (http://nnw.fm/AiZ6a), the company is invested in a transdermal lipid-based nano-dispersion technology that enhances skin absorption of cannabinoids, and the company’s water soluble, oral delivery product, PGS-N001, is designed to provide relief to cancer…

Continue Reading